Equities

Kim Forest Enterprise Co Ltd

6645:TAI

Kim Forest Enterprise Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)27.85
  • Today's Change-0.10 / -0.36%
  • Shares traded32.00k
  • 1 Year change-33.69%
  • Beta--
Data delayed at least 20 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments187125181
Total Receivables, Net112161119
Total Inventory1148780
Prepaid expenses17147.17
Other current assets, total251717
Total current assets455405404
Property, plant & equipment, net456415219
Goodwill, net------
Intangibles, net6.901.522.82
Long term investments--095
Note receivable - long term------
Other long term assets211617
Total assets970847743
LIABILITIES
Accounts payable968757
Accrued expenses------
Notes payable/short-term debt731530
Current portion long-term debt/capital leases201811
Other current liabilities, total824636
Total current liabilities271166134
Total long term debt1189463
Total debt211127104
Deferred income tax0.130.01--
Minority interest--(0.47)0.17
Other liabilities, total3.263.704.54
Total liabilities392264201
SHAREHOLDERS EQUITY
Common stock490403310
Additional paid-in capital177125142
Retained earnings (accumulated deficit)(89)5589
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.020.12(0.17)
Total equity578583542
Total liabilities & shareholders' equity970847743
Total common shares outstanding514848
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.